These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 8967975

  • 1. Cisplatin, camptothecin, and taxol sensitivities of cells with p53-associated multidrug resistance.
    Vasey PA, Jones NA, Jenkins S, Dive C, Brown R.
    Mol Pharmacol; 1996 Dec; 50(6):1536-40. PubMed ID: 8967975
    [Abstract] [Full Text] [Related]

  • 2. Disruption of p53 function in immortalized human cells does not affect survival or apoptosis after taxol or vincristine treatment.
    Fan S, Cherney B, Reinhold W, Rucker K, O'Connor PM.
    Clin Cancer Res; 1998 Apr; 4(4):1047-54. PubMed ID: 9563901
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Accumulation of mutant p53(V143A) modulates the growth, clonogenicity, and radiochemosensitivity of malignant glioma cells independent of endogenous p53 status.
    Bartussek C, Naumann U, Weller M.
    Exp Cell Res; 1999 Dec 15; 253(2):432-9. PubMed ID: 10585266
    [Abstract] [Full Text] [Related]

  • 5. Exogenous mutant p53 DNA enhanced cisplatin-induced apoptosis in TSGH-8301 human bladder cancer cells.
    Chang FL, Ling YF, Lai MD.
    Anticancer Res; 2000 Dec 15; 20(1A):329-36. PubMed ID: 10769676
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Oncolytic herpes simplex virus-1 lacking ICP34.5 induces p53-independent death and is efficacious against chemotherapy-resistant ovarian cancer.
    Coukos G, Makrigiannakis A, Kang EH, Rubin SC, Albelda SM, Molnar-Kimber KL.
    Clin Cancer Res; 2000 Aug 15; 6(8):3342-53. PubMed ID: 10955822
    [Abstract] [Full Text] [Related]

  • 10. Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin.
    Kolfschoten GM, Hulscher TM, Schrier SM, van Houten VM, Pinedo HM, Boven E.
    Gynecol Oncol; 2002 Mar 15; 84(3):404-12. PubMed ID: 11855878
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Regulation of BRCA1 and BRCA2 transcript in response to cisplatin, adriamycin, taxol and ionising radiation is correlated to p53 functional status in ovarian cancer cell lines.
    Aunoble B, Bernard-Gallon D, Bignon YJ.
    Oncol Rep; 2001 Mar 15; 8(3):663-8. PubMed ID: 11295099
    [Abstract] [Full Text] [Related]

  • 14. Human bladder cancer cells undergo cisplatin-induced apoptosis that is associated with p53-dependent and p53-independent responses.
    Konstantakou EG, Voutsinas GE, Karkoulis PK, Aravantinos G, Margaritis LH, Stravopodis DJ.
    Int J Oncol; 2009 Aug 15; 35(2):401-16. PubMed ID: 19578756
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Bcl-xL is expressed in ovarian carcinoma and modulates chemotherapy-induced apoptosis.
    Liu JR, Fletcher B, Page C, Hu C, Nunez G, Baker V.
    Gynecol Oncol; 1998 Sep 15; 70(3):398-403. PubMed ID: 9790794
    [Abstract] [Full Text] [Related]

  • 17. Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy.
    Judson PL, Watson JM, Gehrig PA, Fowler WC, Haskill JS.
    Cancer Res; 1999 May 15; 59(10):2425-32. PubMed ID: 10344753
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The p53-stabilizing compound, CP-31398, does not enhance chemosensitivity in human melanoma cells.
    Luu Y, Li G.
    Anticancer Res; 2003 May 15; 23(1A):99-105. PubMed ID: 12680200
    [Abstract] [Full Text] [Related]

  • 20. Influence of the phosphodiesterase-5 inhibitor, sildenafil, on sensitivity to chemotherapy in breast tumor cells.
    Di X, Gennings C, Bear HD, Graham LJ, Sheth CM, White KL, Gewirtz DA.
    Breast Cancer Res Treat; 2010 Nov 15; 124(2):349-60. PubMed ID: 20155316
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.